SCHEMBL2401504

SCHEMBL2401504

CCCCCCCCCCCCOC(O)C(CCCC)CCCCCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.43
DNM1 Q05193 2/20 0.42
USP2 O75604 1/20 0.40
GPR84 Q9NQS5 4/20 0.39
SPHK1 Q9NYA1 2/20 0.39
FFAR1 O14842 1/20 0.39
LMNA P02545 2/20 0.39
CYP2D6 P10635 2/20 0.37
GMNN O75496 1/20 0.37
POLB P06746 1/20 0.37
THPO P40225 1/20 0.37
MTOR P42345 1/20 0.37
BLM P54132 1/20 0.37
KDM4E B2RXH2 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
MAPT P10636 1/20 0.37
CETP P11597 1/20 0.37
UBE2N P61088 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21295572 0.98 HTT (0.44) HTTDNM1USP2GPR84SPHK1
SCHEMBL26925526 0.91 SPHK1 (0.40) HTTDNM1USP2GPR84SPHK1
SCHEMBL28071184 0.90 HTT (0.42) HTTDNM1USP2SPHK1MAPT
SCHEMBL3237751 0.88 ALDH1A1 (0.51) FFAR1
SCHEMBL8990536 0.86 USP2 (0.43) HTTDNM1USP2SPHK1LMNA
SCHEMBL27355332 0.86 ALDH1A1 (0.42) HTTDNM1USP2
SCHEMBL22057293 0.86 HTT (0.32) HTTDNM1LMNA
SCHEMBL28378452 0.86 GPR84 (0.41) HTTDNM1GPR84SPHK1FFAR1
SCHEMBL25099714 0.82 LMNA (0.38) HTTDNM1USP2SPHK1LMNA
SCHEMBL28588295 0.82 SPHK1 (0.50) HTTDNM1USP2GPR84SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130195776-A1 COSMETIC COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND A BACTERIAL EXTRACT L'OREAL S.A. (FR) 2013-08-01 US disclosed
EP-2542215-A2 COSMETIC COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND A BACTERIAL EXTRACT L'Oréal (FR) 2013-01-09 EP disclosed
WO-2011107433-A2 COSMETIC COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND A BACTERIAL EXTRACT L'OREAL (FR) 2011-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130195776-A1 COSMETIC COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND A BACTERIAL EXTRACT CUTA, PRKDC, FEN1 HTT 258/4885DNM1 85/4885USP2 3887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.